CVL Risk After Severe Glaucoma Surgery

Clinical trial NCT07237555 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07237555
Sponsor: Gangnam Severance Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Severe-stage Glaucoma (Mean Deviation ≤ -20 dB)

Start date: 2024-11-27
Primary completion: 2025-11-26
Enrollment: 523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.